Full Text View
Tabular View
No Study Results Posted
Related Studies
Safety Study of Preservon-Treated Bone Implants for Cervical Fusion in the Treatment of Cervical Radiculopathy or Myelopathy
This study is currently recruiting participants.
Verified by LifeNet Health, January 2009
First Received: June 23, 2006   Last Updated: January 16, 2009   History of Changes
Sponsored by: LifeNet Health
Information provided by: LifeNet Health
ClinicalTrials.gov Identifier: NCT00344890
  Purpose

The purpose of this study is to compare the safety and efficacy of Preservon(TM) treated allograft bone dowels to traditional freeze-dried allograft bone dowels (control) for fusion of degenerated cervical intervertebral discs in the treatment of cervical radiculopathy or myelopathy.

Patient follow-up will be conducted at 6 weeks, 3 months, and 6 months. At 3 months after surgery, the implanted bone dowels will be assessed for subsidence; at 6 months after surgery, the implanted bone dowels will be assessed for fusion. Patients will complete questionnaires and x-rays taken at each visit.

The degree of subsidence and rate of fusion will be assessed based on the evaluation of the x-rays taken. The x-ray evaluation will be conducted by a neurosurgeon who is blinded to the type of treatment that each patient has received.


Condition Intervention
Cervical Radiculopathy
Myelopathy
Procedure: Anterior Cervical Discectomy and Fusion

Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind (Outcomes Assessor), Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title: A Safety and Efficacy Comparison of Preservon Treated Allograft Bone Dowels Versus Traditional Freeze-Dried Allograft Bone Dowels for Fusion of Degenerated Cervical Intervertebral Discs in the Treatment of Cervical Radiculopathy or Myelopathy

Resource links provided by NLM:


Further study details as provided by LifeNet Health:

Primary Outcome Measures:
  • Degree of subsidence [ Time Frame: 3 months post-op ] [ Designated as safety issue: No ]
  • Rate of fusion [ Time Frame: 6 months post-op ] [ Designated as safety issue: No ]

Estimated Enrollment: 120
Study Start Date: September 2006
Estimated Primary Completion Date: May 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Preservon: Experimental Procedure: Anterior Cervical Discectomy and Fusion
1,2,3,or 4 level surgery
Control: Active Comparator Procedure: Anterior Cervical Discectomy and Fusion
1,2,3,or 4 level surgery

  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient is skeletally mature
  • Patient has confirmed radiculopathy or myelopathy
  • Pain unresponsive to non-operative treatment
  • Radicular pain in either or both upper extremities
  • Neurological deficit in distribution of nerve root from C3/4 to C6/7
  • Patient's lateral cervical spine x-rays show inferior aspect of lowest vertebral body to be fused
  • Patient agrees to comply with protocol
  • Patient can provide voluntary informed consent and follow-up information

Exclusion Criteria:

  • Patient has previous cervical spine surgery
  • Patient requires concurrent posterior surgery at level to be treated, or anterior and posterior surgery at any other cervical level
  • Patient has clinically compromised vertebral body structure
  • Patient has multi-level fixed/ankylosed cervical spine
  • Patient has signs of significant instability at level to be treated or adjacent level
  • Patient has history of metabolic bone disease
  • Patient is taking chronic oral/IV corticosteroid therapy OR medications that potentially interfere with bone/soft tissue healing
  • Patient has progressive neuromuscular disease, rheumatoid arthritis, active malignancy, OR any other condition that interferes with self-assessment of pain, function, or quality of life
  • Patient has OPLL at any level
  • Patient has active infection, local or systemic
  • Patient is pregnant or considering pregnancy (x-ray requirements)
  • Patient is participating in another investigational study
  • Patient belongs to vulnerable population
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00344890

Contacts
Contact: Bruce E. Mathern, M.D. 804-828-9165 bmathern@mcvh-vcu.edu
Contact: Robert S. Graham, M.D. 804-828-9165 rgraham@mcvh-vcu.edu

Locations
United States, Virginia
VCU Medical Center Recruiting
Richmond, Virginia, United States, 23298-0631
Contact: Bruce E Mathern, MD     804-828-9165     bmathern@mcvh-vcu.edu    
Sponsors and Collaborators
LifeNet Health
Investigators
Principal Investigator: Bruce E. Mathern, M.D. VCU Medical Center
  More Information

No publications provided

Responsible Party: LifeNet Health ( Dr. Mark Moore )
Study ID Numbers: CR06-001, WIRB Protocol #20061453
Study First Received: June 23, 2006
Last Updated: January 16, 2009
ClinicalTrials.gov Identifier: NCT00344890     History of Changes
Health Authority: United States: Institutional Review Board

Keywords provided by LifeNet Health:
Cervical fusion
Anterior Cervical Discectomy and Fusion
ACDF

Study placed in the following topic categories:
Neuromuscular Diseases
Spinal Cord Diseases
Peripheral Nervous System Diseases
Radiculopathy
Central Nervous System Diseases

Additional relevant MeSH terms:
Neuromuscular Diseases
Spinal Cord Diseases
Peripheral Nervous System Diseases
Nervous System Diseases
Radiculopathy
Central Nervous System Diseases

ClinicalTrials.gov processed this record on September 11, 2009